Provides a comprehensive analysis of both coding and non-coding regions of a patient’s genome to identify genetic diseases with high accuracy. It is ideal for complex or undiagnosed cases. Unlike single-gene tests or exome sequencing, WGS examines nearly the entire genome, detecting a broader range of genetic variants.

​

• Preventive care, family planning, and carrier screening.

• Diagnosing complex or rare diseases.

• Rapid diagnosis in critical care settings (e.g., NICU/PICU).

Focuses on sequencing the protein-coding regions of the genome (exome) to diagnose genetic diseases by identifying disease-causing variants. WES targets ~85% of known disease-causing mutations in the protein-coding regions, offering quicker results and deeper sequencing compared to WGS.

​

• Preventive care and family planning.

• Diagnosing rare or complex genetic disorders, especially when WGS is unnecessary or unavailable.

Utilizes advanced technology and expert medical support—including mobile blood draw services and board-certified genetic counselors—to determine whether individuals are carriers of genetic conditions. This enables informed decision-making for family planning.

​

• Preconception and prenatal screening.

• Testing before IVF or sperm/oocyte donation.

Screens newborns for 355 inherited metabolic disorders using next-generation sequencing.

​

• Early diagnosis of metabolic, amino acid, fatty acid, and endocrine disorders, among others.

• Offers early detection and intervention, reducing the risk of permanent health damage with an accuracy rate of over 99%.

​

Provides comprehensive genetic testing for rare diseases, helping diagnose conditions that may be overlooked by traditional methods. It identifies the molecular causes of rare diseases, leading to personalized treatments and more effective care.

​

• Diagnosing genetic causes of rare diseases.

• Reduces the diagnostic odyssey by offering quick, accurate results using next-generation sequencing.

Analyzes how genes affect individual responses to medications, enabling personalized medication plans that optimize drug efficacy and minimize adverse effects.

​

• Tailors drug treatments based on genetic profiles.

• Reduces the risk of medication side effects.

• Enhances the efficacy of prescribed medications.

Assesses an individual’s genetic predisposition to polygenic diseases, such as heart disease and diabetes, helping to predict risk and manage preventive health strategies.

​

• Identifies genetic risk factors for common diseases.

• Helps implement early lifestyle modifications.

• Predicts long-term health risks to support preventive care.

Matches organ donors and recipients more accurately, improving transplant success rates by identifying compatible tissue types and minimizing rejection risks.

​

• Increases organ transplant success.

• Reduces the risk of rejection.

• Essential for organ transplant planning.